[go: up one dir, main page]

NZ747861B2 - Composition for improving brain function for neonates - Google Patents

Composition for improving brain function for neonates Download PDF

Info

Publication number
NZ747861B2
NZ747861B2 NZ747861A NZ74786117A NZ747861B2 NZ 747861 B2 NZ747861 B2 NZ 747861B2 NZ 747861 A NZ747861 A NZ 747861A NZ 74786117 A NZ74786117 A NZ 74786117A NZ 747861 B2 NZ747861 B2 NZ 747861B2
Authority
NZ
New Zealand
Prior art keywords
neonates
brain function
bifidobacterium
composition
use according
Prior art date
Application number
NZ747861A
Other versions
NZ747861A (en
Inventor
Satoshi Kusuda
Masaki Terahara
Satsuki TOTSU
Original Assignee
Meiji Co Ltd
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Priority claimed from PCT/JP2017/014915 external-priority patent/WO2017179602A1/en
Publication of NZ747861A publication Critical patent/NZ747861A/en
Publication of NZ747861B2 publication Critical patent/NZ747861B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/517—Bifidum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Abstract

object of the present invention is to provide a brain function improving agent for neonates, especially, newborn neonates. According to the present invention, there is provided a brain function improving agent for neonates, comprising a lactic acid bacterium and/or a Bifidobacterium. The brain function improving agent or composition for improving brain function for neonates according to the present invention is advantageous in that the use thereof can improve the developmental quotient without any side effect and also enables effective development and growth of neonates.

Claims (5)

1. Use of a Bifidobacterium for improving the developmental quotient in neonates, wherein the Bifidobacterium is Bifidobacterium bifidum.
2. The use according to claim 1, wherein the Bifidobacterium bifidum is the Bifidobacterium bifidum OLB6378 strain (Accession No. NITE BP-31).
3. The use according to any one of claims 1 to 2, wherein the Bifidobacterium is a sterilized bacterial cell.
4. The use according to any one of claims 1 to 3, wherein the Bifidobacterium bifidum is continuously fed in a bacterial count of 10 or more per day for one month or longer.
5. The use according to any one of claims 1 to 4, wherein the Bifidobacterium bifidum is added to a food product.
NZ747861A 2017-04-12 Composition for improving brain function for neonates NZ747861B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016080676 2016-04-13
PCT/JP2017/014915 WO2017179602A1 (en) 2016-04-13 2017-04-12 Brain function-improving composition for newborns

Publications (2)

Publication Number Publication Date
NZ747861A NZ747861A (en) 2024-09-27
NZ747861B2 true NZ747861B2 (en) 2025-01-07

Family

ID=

Similar Documents

Publication Publication Date Title
Langa et al. In situ reuterin production by Lactobacillus reuteri in dairy products
PH12020550069A1 (en) Process for purifying sialylated oligosaccharides
EP4257194A3 (en) Use of microbial communities for human and animal health
PH12015502416A1 (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
CY1113187T1 (en) ISOLATED STRAIN OF MICROORGANISM LACTOBACILLUS PLANTARUM TENSIA DSM 21380 AS antimicrobial and antihypertensive probiotic, FOOD AND COMPOSITION CONTAINING THE SAID MICRO-ORGANISM AND USE OF THIS MICROORGANISM FOR THE PRODUCTION OF A antihypertensives AND MEDOTHOS FOR THE SUPPRESSION OF PATHOGENIC AND Lactobacillus NOT USED AS Dough IN A FOOD
MY197201A (en) Novel probiotics bifidobacteria strains
BRPI0710944B8 (en) biologically pure culture, and, composition and method to reduce infantile colic
MX2013004343A (en) Texturizing lactic acid bacteria strains.
MX2022008789A (en) Compositions and methods for controlling undesirable microbes and improving animal health.
Denkova et al. Antimicrobial activity of probiotic lactobacilli, bifidobacteria and propionic acid bacteria, isolated from different sources
EA201991967A1 (en) COMPOSITION OF LACTIC ACID BACTERIA FOR PRODUCING FERMENTED FOOD PRODUCTS WITH IMPROVED NATURAL SWEET AND TASTE
GB2549400A (en) Creped prebiotic tissue
EP4148119A4 (en) Novel lactic acid bacteria having excellent immune function enhancement effect, and food composition, health functionl food composition and probiotics comprising same
IN2012DN02283A (en)
FI20075539L (en) Lactic acid bacteria with proinflammatory properties
MX2021000631A (en) Microbiological process for the production of bee bread.
EA202191106A1 (en) PROBIOTIC SUPPLEMENT FOR METABOLIC HEALTH CONTAINING LACTOBACILLUS
PL2166083T3 (en) Novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof
NZ747861B2 (en) Composition for improving brain function for neonates
NZ747861A (en) Composition for improving brain function for neonates
MX2014012156A (en) Ampicillin resistant texturizing lactic acid bacteria strains.
MX2020007906A (en) Composition comprising new lactobacillus salivarius strains and method for the prevention and treatment of otitis and upper respiratory infections.
EP3649866A3 (en) New lactic acid bacteria for preventing infections with listeria species, compositions comprising said strains and uses thereof
MX2023009788A (en) Lactic acid bacteria composition for preparing fermented products.
Poormontaseri et al. Growth rates of Bacillus species probiotics using various enrichment media